BioCentury | Sep 5, 2016
Clinical News

HLD100: Phase II started

...Toronto, Ontario Product: HLD100 Business: Neurology Molecular target: NA Description: Delayed- and extended-release formulation of dextroamphetamine...
BioCentury | May 23, 2016
Company News

Neos Therapeutics sales and marketing update

...plc (LSE:SHP; NASDAQ:SHPG, Dublin, Ireland) alleged that Neos’ NDA infringed Shire’s patents covering Adderall XR dextroamphetamine/amphetamine...
BioCentury | Feb 1, 2016
Clinical News

Adzenys XR-ODT amphetamine regulatory update

...via the 505(b)(2) pathway after Neos demonstrated its bioequivalence to approved ADHD drug Adderall XR dextroamphetamine/amphetamine...
BioCentury | Jan 29, 2016
Company News

Neos rises after ADHD approval

...via the 505(b)(2) pathway after Neos demonstrated its bioequivalence to approved ADHD drug Adderall XR dextroamphetamine/amphetamine...
BioCentury | Sep 7, 2015
Clinical News

Amphetamine XR-ODT regulatory update

...which Shire alleged that the NT-0202 NDA infringed Shire’s patents covering ADHD drug Adderall XR dextroamphetamine/amphetamine...
BioCentury | Nov 24, 2014
Company News

Shire pharmaceuticals news

...million to resolve allegations over its sales, marketing and promotion of ADHD drugs Adderall XR dextroamphetamine/amphetamine...
BioCentury | Oct 20, 2014
Company News

Shire, Neos Therapeutics deal

...FDA for NT-0202 infringed Shire's U.S. Patent Nos. RE 42,096 and 41,148 covering Adderall XR dextroamphetamine/amphetamine...
BioCentury | Aug 11, 2014
Strategy

Profusion of exclusions

..."Out in the Cold." BioCentury 1-7 (Dec. 16, 2013) Tables CVS exclusions update Adderall XR dextroamphetamine/amphetamine...
BioCentury | Dec 9, 2013
Company News

Shire, Novartis sales and marketing update

...subsidiary will supply Novartis' Sandoz unit with an authorized generic version of Shire's Adderall XR dextroamphetamine/amphetamine...
...subsidiary will supply Novartis' Sandoz unit with an authorized generic version of Shire's Adderall XR dextroamphetamine/amphetamine...
BioCentury | Sep 30, 2013
Regulation

Wake-up call

...narcolepsy: Xyrem; Provigil modafinil and Nuvigil armodafinil from Teva Pharmaceutical Industries Ltd. ; and Adderall dextroamphetamine/amphetamine...
Items per page:
1 - 10 of 40